Life Sciences · near ·
Pharma brand budgets shift toward content services bundled with automated regulatory review and citation checks
Mid-tier independent medical communications agencies are suffering steep fee compression as automated writing tools commoditise standard marketing content. Concurrently, pharmaceutical brands are abandoning unvetted generative tools in favour of vertical platforms with embedded Medical Legal Regulatory review workflows and automated citation checking. Agencies that lack doctoral-level scientific depth or proprietary compliance software must merge with software providers or face commercial disintermediation by turnkey tech-enabled platforms.
Part of the Healthcare & Life Sciences Opportunity Outlook, Korim's monthly analysis of emerging opportunities in this sector.